Jacobs Engineering Group stock hits all-time high at 161.9 USD

Published 15/10/2025, 20:16
Jacobs Engineering Group stock hits all-time high at 161.9 USD

Jacobs Engineering Group stock reached an all-time high of 161.9 USD, marking a significant milestone for the $19.32 billion engineering giant. According to InvestingPro analysis, the stock appears slightly overvalued at current levels, trading at a P/E ratio of 40.7. Over the past year, the stock has experienced a notable increase, with a 1-year change of 14.55%, while delivering an impressive 36.5% return in just the last six months. This upward trajectory reflects investor confidence and the company’s strong performance in the engineering and construction sector, with the company maintaining a steady 0.81% dividend yield. The stock’s rise to its highest level ever underscores its resilient growth amidst a competitive market landscape. InvestingPro subscribers can access 12 additional key insights about Jacobs Engineering Group, including detailed valuation metrics and growth indicators.

In other recent news, Jacobs has been selected by Dallas Fort Worth International Airport to spearhead a digital transformation initiative using artificial intelligence and machine learning to enhance airport operations. This project aims to address operational challenges and create scalable models for future innovations. Meanwhile, S&P Global Ratings has revised its outlook for Jacobs Engineering Group to positive from stable, affirming the company’s ratings and expecting it to maintain leverage targets despite ongoing shareholder returns. KeyBanc has reiterated its Overweight rating on Jacobs, maintaining a $157.00 price target after meetings with company executives. Additionally, Jacobs has been chosen by the New York State Department of Transportation to provide design services for infrastructure improvements in the lower Hudson Valley region. The projects will include bridge replacements and highway rehabilitations across several counties. In another development, Jacobs will manage a new pediatric hospital project in Dallas, a joint venture aimed at expanding healthcare capacity in response to the area’s growing pediatric population.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.